Olivier Touzelet

1.1k total citations
16 papers, 746 citations indexed

About

Olivier Touzelet is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Olivier Touzelet has authored 16 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Infectious Diseases and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Olivier Touzelet's work include Respiratory viral infections research (10 papers), Viral Infections and Vectors (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Olivier Touzelet is often cited by papers focused on Respiratory viral infections research (10 papers), Viral Infections and Vectors (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Olivier Touzelet collaborates with scholars based in United Kingdom, Bangladesh and France. Olivier Touzelet's co-authors include Ultan F. Power, Michael D. Shields, Sandrine Henri, François Fay, Marija Zaric, Ryan F. Donnelly, Oksana Lyubomska, Candice Poux, Dorothea Terhorst‐Molawi and Christopher J. Scott and has published in prestigious journals such as ACS Nano, PLoS ONE and Journal of Virology.

In The Last Decade

Olivier Touzelet

15 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Touzelet United Kingdom 12 307 254 211 156 144 16 746
Hye‐Ran Cha South Korea 16 120 0.4× 415 1.6× 97 0.5× 23 0.1× 131 0.9× 28 822
Carlos R. Zárate-Bladés Brazil 16 255 0.8× 296 1.2× 203 1.0× 29 0.2× 23 0.2× 42 927
Jorge E. Arrese Belgium 20 512 1.7× 47 0.2× 116 0.5× 45 0.3× 54 0.4× 48 944
Pramod Upadhyay India 13 129 0.4× 171 0.7× 83 0.4× 32 0.2× 36 0.3× 47 542
In Su Cheon United States 18 238 0.8× 523 2.1× 187 0.9× 143 0.9× 10 0.1× 34 954
María C. Pistoresi‐Palencia Argentina 16 128 0.4× 542 2.1× 55 0.3× 28 0.2× 22 0.2× 46 889
D. Kaiserlian France 17 110 0.4× 416 1.6× 80 0.4× 15 0.1× 24 0.2× 30 805
Sarat K. Dalai India 16 176 0.6× 487 1.9× 60 0.3× 9 0.1× 42 0.3× 45 948
Amin E. Moghaddam United Kingdom 10 253 0.8× 295 1.2× 94 0.4× 55 0.4× 5 0.0× 10 875
Leroy W. Wheeler United States 9 62 0.2× 414 1.6× 90 0.4× 29 0.2× 19 0.1× 13 946

Countries citing papers authored by Olivier Touzelet

Since Specialization
Citations

This map shows the geographic impact of Olivier Touzelet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Touzelet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Touzelet more than expected).

Fields of papers citing papers by Olivier Touzelet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Touzelet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Touzelet. The network helps show where Olivier Touzelet may publish in the future.

Co-authorship network of co-authors of Olivier Touzelet

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Touzelet. A scholar is included among the top collaborators of Olivier Touzelet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Touzelet. Olivier Touzelet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Brady, Gareth, William McCormack, Adam H. Dyer, et al.. (2023). Type 1 interferon auto-antibodies are elevated in patients with decompensated liver cirrhosis. Clinical & Experimental Immunology. 215(2). 177–189.
2.
Broadbent, Lindsay, Connor Bamford, Guillermo López–Campos, et al.. (2022). An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells. PLoS ONE. 17(4). e0266412–e0266412. 9 indexed citations
3.
Bamford, Connor, Lindsay Broadbent, Elihú Aranday-Cortés, et al.. (2022). Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell Lines. Viruses. 14(2). 325–325. 3 indexed citations
4.
Vázquez, Ramiro, María E. Riveiro, Julie A. Gormley, et al.. (2021). Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy. Frontiers in Oncology. 10. 589218–589218. 25 indexed citations
5.
Touzelet, Olivier, Lindsay Broadbent, Stuart D. Armstrong, et al.. (2020). The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins. Molecular & Cellular Proteomics. 19(5). 793–807. 19 indexed citations
6.
Shields, Michael D., et al.. (2019). Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection. Pathogens. 8(3). 106–106. 57 indexed citations
7.
Aljabr, Waleed, Stuart D. Armstrong, Natasha Y. Rickett, et al.. (2019). High Resolution Analysis of Respiratory Syncytial Virus Infection In Vivo. Viruses. 11(10). 926–926. 9 indexed citations
8.
Clarke, Rebecca, Clare Brady, Olivier Touzelet, et al.. (2017). Respiratory virus infection up-regulates TRPV1, TRPA1 and ASICS3 receptors on airway cells. PLoS ONE. 12(2). e0171681–e0171681. 66 indexed citations
9.
Aljabr, Waleed, Olivier Touzelet, Georgios Pollakis, et al.. (2015). Investigating the Influence of Ribavirin on Human Respiratory Syncytial Virus RNA Synthesis by Using a High-Resolution Transcriptome Sequencing Approach. Journal of Virology. 90(10). 4876–4888. 31 indexed citations
10.
García-Dorival, Isabel, Weining Wu, Stuart Dowall, et al.. (2014). Elucidation of the Ebola Virus VP24 Cellular Interactome and Disruption of Virus Biology through Targeted Inhibition of Host-Cell Protein Function. Journal of Proteome Research. 13(11). 5120–5135. 72 indexed citations
11.
Gupta, Nimesh, Jérôme LeGoff, Soulaïma Chamat, et al.. (2013). Affinity-Purified Respiratory Syncytial Virus Antibodies from Intravenous Immunoglobulin Exert Potent Antibody-Dependent Cellular Cytotoxicity. PLoS ONE. 8(7). e69390–e69390. 15 indexed citations
13.
Villenave, Rémi, Surendran Thavagnanam, Olivier Touzelet, et al.. (2011). Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells. Virology Journal. 8(1). 43–43. 56 indexed citations
14.
Villenave, Rémi, Olivier Touzelet, Surendran Thavagnanam, et al.. (2010). Cytopathogenesis of Sendai Virus in Well-Differentiated Primary Pediatric Bronchial Epithelial Cells. Journal of Virology. 84(22). 11718–11728. 26 indexed citations
15.
Touzelet, Olivier, Noureddine Loukili, Thierry Pelet, et al.. (2008). De novo generation of a non-segmented negative strand RNA virus with a bicistronic gene. Virus Research. 140(1-2). 40–48. 14 indexed citations
16.
Elliott, Joanne, Oonagh T. Lynch, Yvonne Suessmuth, et al.. (2007). Respiratory Syncytial Virus NS1 Protein Degrades STAT2 by Using the Elongin-Cullin E3 Ligase. Journal of Virology. 81(7). 3428–3436. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026